Product Usage: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

We are one of the few specialized suppliers offering Pasireotide (SOM230), the next-generation cyclohexapeptide somatostatin analogue. Unlike first-generation analogues (Octreotide/Lanreotide) that primarily target the sst2 receptor, Pasireotide is engineered to exhibit a broad binding profile, showing high affinity for sst1, sst2, sst3, and sst5. We provide this complex, high-value API to advanced research institutions and pharmaceutical companies investigating Cushing’s disease and refractory neuroendocrine tumors.